LAST NEWS
24 April 2019
Update on legal proceedings progress
On April 22, 2019, set by the Commercial Court of Mont de Marsan for the submission of a takeover offer, one potential buyer submitted an improved offer to take over part of the activities…
16 April 2019
Update on legal proceedings progress
According to the judgment of 25 January 2019 declaring the opening of the insolvency proceedings of Europlasma and the Group companies (see press release of 25/01/2019), the Commercial…
5 April 2019
Details concerning BSAR exercise
As part of the ongoing proceedings, Europlasma recalls that the share price as well as BSAR B and C of the Company have been suspended since 20 March 2019. Read the press release (in…
26 March 2019
Legal proceedings update
As part of the ongoing proceedings (see press release of 25/01/2019), the Commercial Court of Mont de Marsan decided, by its judgment of January 25, 2019, to set up a period of observation…
20 March 2019
Europlasma shares trading is suspended pending a press release
Europlasma asked Euronext Paris to suspend the trading of its shares (FR0000044810-ALEUP) from today at 9:00am (Paris time). Read the press release (in French)
25 January 2019
Group’s update
Declaration of cessation of payments Cancellation of the General Shareholders' Meeting convened on 25/02/2019 Resumption of trading of Europlasma shares Read the press release
21 January 2019
Europlasma shares trading is suspended pending a press release
Europlasma asked Euronext Paris to suspend the trading of its shares (FR0000044810-ALEUP) from today before the opening of the stock exchange. Read the press release (in French)
11 January 2019
Invitation to General Meeting of Shareholders
The Board of Directors of Europlasma met today, as part of a warning procedure from its Statutory Auditors, to convene an Ordinary General Meeting to deliberate on the situation of the…
7 December 2018
Update on funding prospects
As stated in the previous press release, Europlasma Group and its management are actively pursuing the objective of achieving a capital increase allowing the entry of a reference…